Moneycontrol

You are Here : See 20% EBITDA growth in FY14: Alembic Pharma

Wednesday, 03:50

In an interview to CNBC-TV18, Amin adds that the company, despite the drug pricing policy, will grow at 15 percent.
JUL 24, 2017
12:13 PM

cnbc tv18 shows

Search
All Shows
Go

NOW PLAYING

Half Time Report

As the name suggests, this show takes stock of the market internals at the half point of the day. On top of the hour, viewers get a recap of all the big moving stocks and experts offer trading strategies for the second half of the day. Hosted by Ekta Batra and Reema Tendulkar, the show covers the gl ... more »

mytv on mobile

Track your portfolio on the go with

moneycontrol app

Sections
Follow us on
Available On